NAV12/6/2016 Chg.+4.3800 Type of yield Investment Focus Investment company
478.8300EUR +0.92% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.57 6.12 6.42 -1.06 3.16 -11.73 4.92 5.03 -
2010 4.64 4.78 5.80 0.08 -5.05 -3.26 -3.14 0.42 4.28 4.50 1.74 4.27 +19.88%
2011 -5.00 -0.58 -1.77 3.43 3.21 -1.63 -1.22 -13.48 -0.20 1.92 4.02 6.76 -5.94%
2012 12.44 -0.50 3.77 0.96 6.42 1.08 6.96 -0.39 3.53 -9.25 4.57 -1.92 +29.46%
2013 4.41 5.53 9.71 6.48 4.70 -4.20 12.28 -2.09 6.27 -3.63 8.04 -0.23 +56.68%
2014 12.36 4.08 -10.71 -4.63 4.48 8.14 1.15 13.08 3.01 11.02 3.10 2.31 +55.24%
2015 15.70 6.35 4.96 -7.88 12.24 -2.01 2.87 -12.82 -12.03 10.61 7.05 -1.90 +19.90%
2016 -22.80 -5.60 -0.37 3.47 6.31 -9.21 12.44 -2.44 1.99 -11.88 12.34 -0.96 -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 33.02% 28.45% 32.87% 30.86% 26.91%
Sharpe ratio -0.65 -0.05 -0.50 0.47 0.98
Best month +12.44% +12.44% +12.44% +15.70% +15.70%
Worst month -22.80% -11.88% -22.80% -22.80% -22.80%
Maximum loss -33.33% -19.95% -33.94% -44.38% -44.38%
Outperformance -11.33% - -8.97% +3.53% +81.43%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 407.7900 -16.85% +19.72%
BB Adamant Biotech I EUR reinvestment 508.8500 -15.92% +52.63%
BB Adamant Biotech I CHF reinvestment 362.7900 -16.13% +35.07%
BB Adamant Biotech B USD reinvestment 385.1600 -17.47% +17.08%
BB Adamant Biotech B CHF reinvestment 340.8100 -16.75% +32.09%
BB Adamant Biotech B EUR reinvestment 478.8300 -16.55% +49.27%

Performance

YTD
  -20.48%
6 Months
  -0.81%
1 Year
  -16.55%
3 Years  
+49.27%
5 Years  
+219.35%
Since start  
+283.06%
Year
2015  
+19.90%
2014  
+55.24%
2013  
+56.68%
2012  
+29.46%
2011
  -5.94%
2010  
+19.88%